GAVILAX

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 17856-0312
  • Package NDC 17856-0312-1
  • Package NDC 17856-0312-2
  • Package NDC 17856-0312-3
  • Package NDC 17856-0312-4
  • Package NDC 17856-0312-5
  • Package NDC 17856-0312-6
  • Package NDC 17856-0312-7
  • Package NDC 17856-0312-8
  • Package NDC 17856-0312-9
  • Application number ANDA091077
  • SPL ID 3a86670e-4e74-3a85-e063-6394a90ad435
  • SPL set ID c9688f06-b6db-4afb-b8ff-ef5fb8bf9946
  • UNII G2M7P15E5P
  • RxCUI 876193
  • RxCUI 876214

What the source publishes

Labeler
ATLANTIC BIOLOGICALS CORP.
Active ingredients
Polyethylene Glycol 3350
Form
POWDER, FOR SOLUTION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN OTC DRUG
Prescription
Non-prescription

Names this record is found by

Complete source data
us:fda:ndc:17856-0312_3a86670e-4e74-3a85-e063-6394a90ad435
{
  "name": "GAVILAX",
  "splId": "3a86670e-4e74-3a85-e063-6394a90ad435",
  "labels": [
    {
      "setId": "c9688f06-b6db-4afb-b8ff-ef5fb8bf9946",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c9688f06-b6db-4afb-b8ff-ef5fb8bf9946",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9688f06-b6db-4afb-b8ff-ef5fb8bf9946"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "ATLANTIC BIOLOGICALS CORP.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "17 g in 1 BAG (17856-0312-1)",
      "package_ndc": "17856-0312-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210126"
    },
    {
      "sample": false,
      "description": "8.5 g in 1 BAG (17856-0312-2)",
      "package_ndc": "17856-0312-2",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210126"
    },
    {
      "sample": false,
      "description": "17 g in 1 CUP (17856-0312-3)",
      "package_ndc": "17856-0312-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210126"
    },
    {
      "sample": false,
      "description": "4 g in 1 BAG (17856-0312-4)",
      "package_ndc": "17856-0312-4",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210126"
    },
    {
      "sample": false,
      "description": "50 CUP in 1 CASE (17856-0312-5)  / 8.5 g in 1 CUP",
      "package_ndc": "17856-0312-5",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210126"
    },
    {
      "sample": false,
      "description": "72 POUCH in 1 CASE (17856-0312-6)  / 4.5 g in 1 POUCH",
      "package_ndc": "17856-0312-6",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210126"
    },
    {
      "sample": false,
      "description": "50 BAG in 1 BOX, UNIT-DOSE (17856-0312-7)  / 4.25 g in 1 BAG",
      "package_ndc": "17856-0312-7",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231010"
    },
    {
      "sample": false,
      "description": "72 BAG in 1 BOX, UNIT-DOSE (17856-0312-8)  / 4.25 g in 1 BAG",
      "package_ndc": "17856-0312-8",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250722"
    },
    {
      "sample": false,
      "description": "50 CUP in 1 BOX, UNIT-DOSE (17856-0312-9)  / 4.25 g in 1 CUP",
      "package_ndc": "17856-0312-9",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250722"
    }
  ],
  "productId": "17856-0312_3a86670e-4e74-3a85-e063-6394a90ad435",
  "useDomain": "unknown",
  "dosageForm": "POWDER, FOR SOLUTION",
  "productNdc": "17856-0312",
  "deaSchedule": null,
  "genericName": "Polyethylene Glycol 3350",
  "productType": "HUMAN OTC DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "POLYETHYLENE GLYCOL 3350",
      "strength": "17 g/17g"
    }
  ],
  "applicationNumber": "ANDA091077",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210126",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "non-prescription",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000010288",
      "N0000175811",
      "N0000009871"
    ],
    "unii": [
      "G2M7P15E5P"
    ],
    "rxcui": [
      "876193",
      "876214"
    ],
    "spl_set_id": [
      "c9688f06-b6db-4afb-b8ff-ef5fb8bf9946"
    ],
    "pharm_class_pe": [
      "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"
    ],
    "pharm_class_epc": [
      "Osmotic Laxative [EPC]"
    ],
    "pharm_class_moa": [
      "Osmotic Activity [MoA]"
    ],
    "manufacturer_name": [
      "ATLANTIC BIOLOGICALS CORP."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:17856-0312_3a86670e-4e74-3a85-e063-6394a90ad435"